Antithrombin III (AT) Activity in Women with Severe Preeclampsia (PE) or Superimposed PE prior to 31weeks (AT3)

Purpose:

The purpose of this study is to see how the levels of Antithrombin (AT) change in women with preeclampsia. AT is an anticoagulant found in human blood. Preeclampsia is a condition that can develop around the 20th week of pregnancy, characterized by high blood pressure, protein in your urine, and water retention/swelling are the primary
symptoms. By studying the levels of AT in your blood during the 23rd to 31 weeks of your pregnancy, we may be able to better understand the effects that AT have in pregnancy complicated by preeclampsia.

Eligibility criteria:

1. Single fetus of 23 0/7 to 30 6/7 weeks’ gestational age
(pregnancies starting as twins but complicated with either vanishing twin syndrome or fetal demise of
one twin before 14 weeks, are eligible for inclusion)
2. Women 18-50 years of old
4. Preeclampsia (specifics to be explained)

Other eligibility requirements to be discussed

Contact Information


Anna Bartholomew, RN
614-685-3229
Anna.Bartholomew@osumc.edu

Back